PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.71

+1.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Perry who wrote (3590)	6/19/1998 4:40:00 PM
From: Anthony Wong	Read Replies (1) of 9523

I don't think analysts would take into account Zeldox's future sales when the drug is not yet approved by the FDA. Usually they revise their earnings estimates when the scripts for the newly approved drug start coming in and they have a better grasp of potential sales. LLY's Zyprexa (approved in late 1996) had $730 million in 1997 sales, and JNJ's Risperdal's 1997 sales (approved 4 years ago) have estimated 1997 sales of more than $840 million, so I would expect Zeldox, with PFE's formidable sales force, to have similar sales figures. Don't know how much more time Pfizer need to do the extra studies: 6 months to one year? PFE's news release didn't provide much information.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next